Email this article The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
- Authors: Chazova I.E.1, Ratova L.G.1, Chazova IE1, Ratova LG1
-
Affiliations:
- Issue: Vol 6, No 1 (2009)
- Pages: 4-11
- Section: Articles
- URL: https://journals.eco-vector.com/2075-082X/article/view/33040
- DOI: https://doi.org/10.26442/SG33040
- ID: 33040
Cite item
Full Text
Abstract
Keywords
References
- Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2008; 7 (6).
- ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 1105-87.
- Task Force Members, Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus document on b-adrenergic receptor blockers. The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J 2004; 25: 1341-62.
- Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the swidish trial in old patients with hypertension (STOP-Hypertension). Lancet 19991; 338: 1281-5.
- Olsson G, Tuomilehto J, Berglund G et al. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY study. Am J Hypertens 1991; 4: 151-8.
- Wiysonge CS, Bradley H, Mayosi BM et al. Beta blockers for hypertension. Cochrane Database Review 2007; 1: CD002003.
- Egstrup et al. The antianginal efficacy and tolerability of controlled-release metoprolol once daily: a comparison with conventional metoprolol tablets twice daily. J Clin Pharmacol 1988; 33.
- Остроумова О.Д., Рыкова А.М. и др. Выбор антигипертензивных препаратов у больных с сочетанием артериальной гипертензии и ишемической болезни сердца: фокус на b-блокаторы. Consilium Medicum 2007; 9 (5).
- Frishman WH. Postinfarction survival: role of beta-adrenic blocade, in Fuster V (ed): Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippencott 1996: 1205-14.
- Omvik P et al. Equal efficacy and improved tolerability with 50 mg controlled-release metoprolol compared with 100 mg conventional metoprolol in hypertensive patients. Am J Ther 1994; 1: 65-73.
- Wiklund O, Hulthe J, Wikstrand J et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002; 33: 572-7.
- Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Clin Med J 1995; 108 (9): 710-7.
- Beckett NS, Peters R, Fletcher AE et al. The HYVET Study Group. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358 (18): 1887-98.
- Gueyffier F, Bulpitt C, Boissel JP et al.; the INDANA Group. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999; 353 (9155): 793-6.
- Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006; 144 (12): 884-93.
Supplementary files
